is retatrutide a glp1 Retatrutide, GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA Retatrutide 40mg Pen | Triple

The compounded medication is typically shipped within 48 business hours of prescription approval

[PMC free article: PMC7136665] [PubMed: 32308449] 45

Elvert R, Herling AW, Bossart M, Weiss T, Zhang B, Wenski P, et al

In other words, its down to the actual, beneficial effect of the drugs that rapid weight-loss rather than the drugs themselves, so there probably wont be any real difference in hair-loss side effects between GLP-1 drugs

Ozempic is FDA-approved for adults with Type 2 diabetes and certain related risks, not as a weight-loss drug

5 Blood vessel lining and plaque stability When chronic inflammation is reduced, artery linings become less permeable to cholesterol, less hospitable to plaque formation, and better able to keep existing plaques stable and contained